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Abstract
Background: Postsynaptic enrichment of acetylcholine receptors (AChRs) at the vertebrate neuromuscular junction (NMJ)
depends on the activation of the muscle receptor tyrosine MuSK by neural agrin. Agrin-stimulation of MuSK is known to
initiate an intracellular signaling cascade that leads to the clustering of AChRs in an actin polymerization-dependent
manner, but the molecular steps which link MuSK activation to AChR aggregation remain incompletely defined.
Methodology/Principal Findings: In this study we used biochemical, cell biological and molecular assays to investigate a
possible role in AChR clustering of cortactin, a protein which is a tyrosine kinase substrate and a regulator of F-actin
assembly and which has also been previously localized at AChR clustering sites. We report that cortactin was co-enriched at
AChR clusters in situ with its target the Arp2/3 complex, which is a key stimulator of actin polymerization in cells. Cortactin
was further preferentially tyrosine phosphorylated at AChR clustering sites and treatment of myotubes with agrin
significantly enhanced the tyrosine phosphorylation of cortactin. Importantly, forced expression in myotubes of a tyrosine
phosphorylation-defective cortactin mutant (but not wild-type cortactin) suppressed agrin-dependent AChR clustering, as
did the reduction of endogenous cortactin levels using RNA interference, and introduction of the mutant cortactin into
muscle cells potently inhibited synaptic AChR aggregation in response to innervation.
Conclusion: Our results suggest a novel function of phosphorylation-dependent cortactin signaling downstream from
agrin/MuSK in facilitating AChR clustering at the developing NMJ.
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Introduction
At the vertebrate neuromuscular junction (NMJ) motor nerve-
secreted acetylcholine (ACh) binds and opens postsynaptic ACh
receptors (AChRs) to initiate excitation along the muscle
membrane and cause contraction. One remarkable feature of
the NMJ is its unfailing postsynaptic response to every nerve-
stimulation, which is made possible by the selective enrichment of
AChRs in muscle within a small membrane domain that apposes
presynaptic ‘‘active zones’’ where synaptic vesicles dock and
release ACh. Whereas ,10,000 AChRs are present per mm
2 of the
synaptic muscle membrane, only ,10 AChRs are found per mm
2
of the extrasynaptic membrane [1]. Thus, in the assembly of the
NMJ, synaptic AChR clustering is a critical and perhaps also the
most studied step [2].
During development AChRs form aggregates in embryonic
muscle fibers even before motor innervation due to the activation
of the muscle receptor tyrosine kinase MuSK [3,4]. This ‘‘pre-
patterned’’ clustering of AChRs in the central regions of muscle
fibers involves, in addition to MuSK, the transmembrane protein
LRP4 [5] and the adapter dok-7 which enhances MuSK signaling
[6]. Next, during innervation, a nerve-deposited heparan-sulfate
proteoglycan named agrin [7] stimulates MuSK to promote
AChR clustering and stabilization locally at synapses [8,9]. How
agrin activates MuSK has remained unclear because agrin does
not bind to MuSK [8], although recent studies suggest that agrin
interacts with LRP4 and that LRP4 binds to MuSK and facilitates
the aggregation and (trans)activation of MuSK [10,11]. Finally, as
AChRs become accumulated at newly established synapses, the
pre-patterned AChR clusters are disassembled, either by synapto-
genic stimuli or by ACh [12,13,14], which helps the selective
concentration of AChRs at NMJs.
How are AChRs concentrated in the postsynaptic membrane?
It is thought that AChRs diffusing freely on the muscle surface
become clustered at traps generated by synaptogenic stimuli at the
NMJ [15]; this diffusion-mediated trapping of AChRs has recently
been directly visualized through single-molecular tracking with
quantum dots [16,17]. The clustering of AChRs is mediated by the
protein rapsyn, which crosslinks and tethers AChRs to the cortical
actin cytoskeleton [2,12,13,18]. F-actin and several proteins that
bind to it are enriched at the NMJ and at AChR clusters in muscle
cells, and inhibition of actin polymerization blocks the aggregation
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Furthermore, AChR clustering involves signaling by Rho-family
GTPases [21], which regulate diverse actin polymerization-driven
processes [22], p21-activated kinase 1, an effector of the GTPase
Cdc42 [23], and geranylgeranyl transferase, an enzyme which
enhances the membrane association and activation of GTPases
[24]. Conversely, inhibition of PI3 kinase signaling in myotubes
reduces agrin-dependent activation of Rac and Cdc42 GTPases
and impedes AChR clustering [25].
The above findings suggest that Rho GTPases influence AChR
aggregation in multiple ways, but little is known about how the
receptor clustering process is affected by other proteins that also
regulate actin polymerization. The focus of this study is on one
such protein – cortactin – which has been shown to localize at
AChR clusters in cultured muscle cells [19,26], but for which no
functional role in NMJ formation has been described to date.
Initially identified as a major src tyrosine kinase substrate in cells
[27,28], cortactin is today recognized as a modulator of numerous
actin polymerization-dependent processes, ranging from cell
motility to endocytosis to dendritic spine growth and synaptogen-
esis in central neurons [29]. An important target of cortactin is the
Arp2/3 protein complex, which binds to existing actin filaments
and initiates new branch growth [30,31]; association of cortactin
with the Arp2/3 complex enhances Arp2/3-induced actin
polymerization [29,32]. Intriguingly, phosphorylation by src
allows cortactin to be linked by the adapter Nck1 to another
Arp2/3-stimulator, N-WASP, and this tripartite complex com-
posed of phospho-cortactin, Nck1 and N-WASP activates Arp2/3-
dependent actin polymerization better than cortactin or N-WASP
alone [33]. In light of these recent findings related to cortactin and
the importance of tyrosine kinase signaling and actin polymeriza-
tion in AChR clustering, here we asked three specific questions: Is
cortactin’s tyrosine phosphorylation relevant in the context of
AChR clustering in situ? Is cortactin’s phosphorylation in muscle
affected by agrin/MuSK signaling? Does cortactin signaling in any
way regulate synaptic AChR aggregation? The results of our cell
biological, biochemical and molecular assays presented below
suggest that phosphorylation-dependent signaling by cortactin
downstream from agrin/MuSK promotes AChR clustering at the
NMJ.
Results
Localization of Actin-Polymerization Regulators at AChR
Clustering Sites
We previously showed that dynamic F-actin assembly occurs at
sites of de novo AChR clustering and that green fluorescent
protein (GFP)-tagged cortactin is recruited to such sites [19,20].
Because the Arp2/3 complex is a key cellular regulator of actin
polymerization and a target of cortactin, we asked whether
proteins of this complex are localized in muscle cells where AChR
clustering is stimulated. Primary cultures of Xenopus embryonic
muscle cells were labeled with rhodamine-a-bungarotoxin (R-
BTX) to mark AChRs and then stimulated with polystyrene beads
coated with heparan-binding growth associated molecule (HB-
GAM); this procedure enables AChR clusters to be induced
reliably and in a spatiotemporally controlled manner [20].
Labeling of bead-treated cells with affinity-purified antibodies
revealed that Arp2 and p34arc, two members of the Arp2/3
complex, were enriched at bead-muscle contacts where AChRs
were focally clustered (Fig. 1, A–F), but numerous unrelated
proteins were not (data not shown). The distribution of the Arp2/3
complex proteins relative to AChRs resembled that of cortactin
[26], which can directly bind to the Arp2/3 complex [32], and
when bead-treated muscle cells were labeled by the polyclonal
anti-p34arc antibody and a monoclonal anti-cortactin antibody,
p34arc and cortactin were found to colocalize at bead-muscle
contacts (Fig. 1, G–I). However, in non-muscle cells which are
found occasionally in primary muscle cultures, p34arc and
cortactin were detected along the cell periphery but not at bead-
contacts (panels J–K), suggesting that the antibodies against
p34arc and cortactin recognized their targets at AChR clusters in
muscle cells and did not simply mark all sites where beads
contacted cells.
Association of Tyrosine-Phosphorylated Cortactin with
AChR Clusters
Because recent work has shown that tyrosine phosphorylation of
cortactin’s src-target sites enhances the activation of Arp2/3-
dependent actin polymerization [32,33], we tested whether
cortactin phosphorylation is relevant in the context of AChR
clustering. For this the distribution of tyrosine-phosphorylated
cortactin relative to AChR clusters was examined in Xenopus
muscle cells by labeling (separately) with three different antibodies
directed against cortactin phosphorylated on its major src-target
sites (Y421, Y466 and Y482 in mouse cortactin). In quiescent
muscle cells anti-Y482-phospho-cortactin antibody strongly la-
beled pre-patterned AChR clusters (Fig. 2, A–F) and also the edges
of cells (where cortactin is known to localize) but only weakly
labeled other regions of the cells. Y482-phosphorylated cortactin
was detected reliably at pre-patterned AChR clusters (panel C),
although sometimes it appeared more concentrated in certain
regions of the clusters than others (panel F). Data from several
muscle culture preparations showed phosphorylation of Y482-
cortactin at .95% of pre-patterned clusters identified (Table S1,
Supporting Documents).
Antibodies against Y421- and Y466-phospho-cortactin also
labeled AChRs clusters and muscle cell edges, but with these two
antibodies staining was somewhat weaker than with anti-Y482-
phospho-cortactin (not shown). It is possible that these commercial
antibodies have differing affinities for their target sites or that these
sites are phosphorylated and/or accessible to different extents.
Unlike these three antibodies, however, many control antibodies
showed markedly different labeling of muscle cells. For example,
a polyclonal antibody against tyrosine-phosphorylated AChR
b-subunit labeled only AChR clusters, two different polyclonal
antibodies against cadherin complex proteins strongly stained
cell junctions but not AChR clusters, and other polyclonal
antibodies either labeled muscle cells uniformly (such as an anti-
phospho-Shp2 phosphatase antibody) or failed to label the cells
(such as anti-synapsin) (R.M., A.W.S.C., H.B.P., unpublished
observations).
Next we examined whether cortactin is phosphorylated at sites
of new AChR cluster formation. In Xenopus nerve-muscle co-
cultures, AChR clusters developed in muscle cells focally at sites
where the cells were contacted by nerves and these clusters were
strongly labeled by the anti-Y482-phospho-cortactin antibody
(Fig. 2, G–I). Phospho-cortactin’s localization closely matched that
of postsynaptic AChR clusters, but labeling for phospho-cortactin
was weak in presynaptic neurites (which were strongly labeled, as
expected, by antibodies against neuronal markers such as
synapsin; not shown). From several nerve-muscle co-culture
preparations we found phospho-cortactin at .80% of nerve-
induced AChR clusters (Table S1). Moreover, in muscle cultures
stimulated with HB-GAM-beads, phospho-cortactin was found to
be enriched at AChR clusters induced at bead-muscle contacts
(Fig. 3, A–C), with pooled data showing that this was the case at
,95% of such clusters (Table S1), and in agrin-treated muscle cells
Cortactin and NMJ Formation
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3 mm in diameter) generated across the muscle surface (Fig. 3,
D–F). Interestingly, phospho-cortactin was also detected along
myopodia (panel D–F) generated close to AChR clusters [34] and
was often concentrated at myopodial tips (arrowheads in panel F).
Taken together these results suggested that phosphorylation of
cortactin’s src-target tyrosines is enhanced at sites in muscle where
synaptogenic stimuli such as agrin produce their known functional
effects.
Agrin-Dependent Tyrosine Phosphorylation of Cortactin
To extend the studies described above we tested whether agrin
signaling directly affects cortactin’s tyrosine phosphorylation
through biochemical assays. For this C2 mouse myotubes were
used because such assays cannot be easily performed on the
limited material provided by Xenopus embryonic muscle primary
cultures. Fully differentiated C2 myotubes were exposed to control
or agrin-containing medium for 1 h and then cortactin was
immuno-precipitated from them for analyses. Blotting of immuno-
precipitates with anti-cortactin and anti-phosphotyrosine antibod-
ies (Fig. 4A, top) showed that the anti-cortactin antibody
(mAb4F11) captured cortactin from extracts but the control
antibody did not (‘‘IB:cort’’, upper blot). Significantly, cortactin
immuno-precipitated from extracts of agrin-treated myotubes was
more strongly stained by the anti-phosphotyrosine antibody than
cortactin captured from extracts of control myotubes (‘‘IB: PY’’,
lower blot). From four such experiments we determined the band
intensities of cortactin stained by anti-cortactin and anti-
phosphotyrosine and then divided the latter values by the former
to normalize for cortactin loading in each case. These results
indicated that cortactin’s tyrosine phosphorylation level in agrin-
treated myotubes was more than twice that in control myotubes
(Fig. 4A, bottom).
As discussed in the previous section, three major src-target sites
have been identified in cortactin. To test whether agrin-treatment
of muscle, which activates src signaling [35], triggers the
Figure 1. Localization of Arp2/3 complex proteins and cortactin at AChR clustering sites. Cultured embryonic Xenopus muscle cells
labeled with rhodamine-a-bungarotoxin (R-BTX) were stimulated overnight with polystyrene beads coated with heparan-binding growth-associated
molecule (HB-GAM) (A, D; asterisks) to induce AChR clusters (C, F). Cells were then fixed and labeled with affinity-purified polyclonal antibodies
against the Arp2/3 complex proteins Arp2 (B) and p34arc (E) followed by FITC-linked anti-rabbit secondary antibodies. Separately, bead-stimulated
muscle cells (G) were labeled with anti-p34arc polyclonal (H) and anti-cortactin monoclonal (I; mAb4F11) antibodies and then FITC-conjugated anti-
rabbit and rhodamine-conjugated anti-mouse secondary antibodies. AChRs, Arp2 and p34arc were clustered at bead-muscle contacts (A-F; arrows)
where cortactin localized and overlapped in distribution with p34arc (H and I; arrows). In primary muscle cultures non-muscle cells were occasionally
found (J) and in these cells p34arc (K) and cortactin (L) localized along the cell periphery (arrowheads) but were not clustered at bead-cell contacts
(‘‘b’’ in K and L corresponds to bead indicated by asterisk in J).
doi:10.1371/journal.pone.0008478.g001
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immuno-blotted with anti-cortactin and anti-Y421-phospho-cor-
tactin antibodies. Both antibodies stained bands of cortactin’s
expected size and anti-cortactin staining showed equal protein
loading (Fig. 4B); with the anti-phospho-cortactin antibody,
however, cortactin was stained nearly three-times more strongly
in extracts of agrin-treated myotubes than of control myotubes
(Fig. 4B, bottom; data from three experiments). Similarly, a band
corresponding to full-length cortactin was detected with the anti-
Y466-phospho-cortactin antibody and this was enhanced by agrin
as well (not shown), but staining by the anti-Y482-phospho-
cortactin antibody in total extracts was weak and we have been
unable to ascertain whether that staining is altered significantly by
agrin-treatment. Nevertheless, these findings and our in situ
labeling results together supported the conclusion that phosphor-
ylation of cortactin’s src-target sites is enhanced during agrin/
MuSK signaling.
Involvement of Cortactin Signaling in
Agrin/Nerve-Induced AChR Clustering
To investigate whether phosphorylation-dependent cortactin
signaling is involved in the AChR clustering process, we expressed
Figure 2. Tyrosine phosphorylation of cortactin at pre-patterned and nerve-induced AChR clusters. Xenopus muscle cells were labeled
with R-BTX and after fixation with an antibody that specifically recognizes Y482-phospho-cortactin (plus FITC-linked anti-rabbit antibodies) (A-F). In
some cases muscle cells were first co-cultured for 1 d with spinal neurons and then labeled with R-BTX and anti-phospho-cortactin and secondary
antibodies (G-I). In pure muscle cultures (A, D) large ‘‘pre-patterned’’ AChR clusters were present (B, E; arrows) and at these sites staining by anti-
phospho-cortactin was significantly stronger than elsewhere in muscle cells (C, F; arrows). Labeling for phospho-cortactin was detected at almost all
pre-patterned clusters examined (see Table S1), although within the clusters certain regions at times appeared to be more enriched in phospho-
cortactin than others (as in F; arrow versus arrowhead). The anti-phospho-cortactin antibody also labeled muscle cell edges (C, F) where cortactin is
known to be localized. In nerve-muscle co-cultures (G) AChRs were selectively concentrated at synaptic contacts (H; arrows) and these nerve-induced
AChR clusters were also labeled by the anti-phospho-cortactin antibody (I; arrows).
doi:10.1371/journal.pone.0008478.g002
Figure 3. Cortactin phosphorylation at AChR clusters induced by growth factor-coated beads and agrin. R-BTX-labeled Xenopus
muscle cells were stimulated overnight with HB-GAM-beads (A-C) or neural agrin (D-F). In cells exposed to beads (A; asterisks) AChRs aggregated at
bead-muscle contacts (B; arrows) and strong labeling was detected at these bead-induced AChR clusters for Y482-phospho-cortactin (C; arrows).
Treatment of muscle cells with agrin (D) generated numerous small (,0.5-3 mm) AChR clusters (D; arrows) and antibody labeling showed that
phospho-cortactin was enriched at these clusters (E; arrows) and also along myopodia that formed near the AChR clusters (F; arrows and arrowheads).
doi:10.1371/journal.pone.0008478.g003
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and wild-type cortactin in C2 myotubes and examined agrin-
induction of AChR clusters. In the mutant cortactin (3YF-
cortactin), the three major src phosphorylation sites – Y421,
Y466 and Y482 – were eliminated [36], and both the mutant and
the wild-type cortactin proteins were tagged with GFP. The GFP-
tagged cortactin proteins (or GFP alone) were expressed in
myotubes by mRNA transfection, which was carried out in parallel
on myotubes grown on coverslips for analysis of AChR clustering
and in culture dishes for biochemically confirming the expression
of the exogenous proteins.
Myotubes growing on coverslips were incubated overnight with
agrin and labeled with R-BTX (Fig. 5) and transfected cells were
identified by green fluorescence. In these we found that compared
to myotubes expressing GFP (panels A–C) or wild-type cortactin-
GFP (panels G–I), those expressing the phospho-mutant cortactin
had fewer and smaller AChR clusters (panels D–F). Immuno-
blotting of extracts of myotubes transfected with mRNAs encoding
the GFP-tagged cortactin proteins (but not GFP) demonstrated
that anti-cortactin monoclonal antibody 4F11 stained endogenous
cortactin plus the exogenous cortactin proteins, which were
,25 kD larger (Fig. 5J). From five separate transfection experi-
ments the numbers and lengths of AChR clusters in green
fluorescent (transfected) myotubes were determined; for this the
myotubes were examined in their entirety and all distinct clusters
(such as those indicated by arrows in Fig. 5) were counted and
measured. Data pooled from 200 or more (each) GFP-cells, wild-
type cortactin-cells and phospho-mutant cortactin-cells showed
that relative to control (GFP) myotubes, the phospho-mutant
cortactin-expressing myotubes had nearly 60% fewer clusters (4.3/
myotube instead of ,10/myotube) which were nearly 30%
smaller (,19 mm long compared to ,27 mm) (Fig. 5, K–L).
The above results demonstrated that agrin-stimulated AChR
clustering in myotubes was inhibited in the presence of exogenous
phospho-mutant cortactin. Therefore, to directly test whether
endogenous cortactin functions in the AChR cluster assembly
process, we down-regulated its expression in myotubes using RNA
interference (RNAi). C2 myoblasts were transfected with GFP
cDNA mixed with a cocktail of mouse cortactin-specific small
interfering RNAs (siRNAs) or siRNAs against unrelated proteins;
cells were then allowed to differentiate for 4 d before they were
treated overnight with agrin. When GFP-positive cells were
examined after labeling with R-BTX, the results showed that
AChR clustering in response to agrin was impaired in cortactin-
siRNA-transfected myotubes compared to control-siRNA-trans-
fected myotubes (Fig. 6, A–F). Immuno-blotting of total cell
extracts from the same batch of myotubes (in each experiment; see
Methods) confirmed that the cortactin-siRNAs down-regulated the
expression of cortactin but did not produce any noticeable change
in the expression of many unrelated proteins (Shp2, SIRPa1, p120
catenin (p120ctn), Arp2, Arp3, Nck1 and tubulin; not shown,
except tubulin in panel G) and that control siRNAs (against Shp2,
SIRPa1 and p120ctn; p120ctn-siRNA used as control in panel G)
did not affect cortactin levels. AChR cluster numbers and lengths
in control siRNA- and cortactin siRNA-transfected myotubes (150
or more each) were measured (see above) and data from four
separate siRNA-transfection experiments revealed that the average
values of these parameters were reduced by ,40% in myotubes
expressing lower than normal levels of cortactin (Fig. 6, H–I).
Is cortactin signaling involved in AChR clustering at the NMJ in
vivo? To answer this, we injected mRNAs encoding GFP or GFP-
tagged wild-type and mutant cortactin proteins into Xenopus
embryos with the goal of examining NMJs that can be observed
(in a ‘‘chevron’’ pattern) in the developing tail muscle. These
Figure 4. Agrin-dependent enhancement of cortactin tyrosine phosphorylation. Cultured C2 mouse myotubes were exposed to medium
without (-) or with added agrin (+) before preparing extracts for immuno-precipitation (A) with a monoclonal antibody against cortactin (IP: cort) or
an unrelated protein (IP: ctl). When these samples were immuno-blotted for cortactin (IB: cort) and total phosphotyrosine (IB: PY; mAb4G10), cortactin
was found to be captured only by the anti-cortactin antibody (upper lanes), and anti-phosphotyrosine staining showed that cortactin from extracts of
agrin-treated cells was tyrosine phosphorylated significantly more than that captured from control extracts (lower lanes). This increase in cortactin
phosphorylation was quantified from four experiments (A, graph) by measuring band densities, normalizing for cortactin loading (see Methods), and
calculating the phosphotyrosine level change relative to control. B. To test whether the src-target sites in cortactin were phosphorylated in response
to agrin-treatment, myotube extracts were blotted with antibodies against total cortactin and cortactin phosphorylated on Y421. Agrin-treatment did
not alter the amount of cortactin present in extracts (upper lanes) but the staining of cortactin by the anti-Y421-phospho-cortactin antibody (IB:
pCort) was enhanced by agrin-treatment more than two-fold, as shown by quantification from three experiments (B, graph). Positions of pre-stained
MW markers (Bio-Rad) are indicated on the right side of blots, and in the graphs * represents P,0.02 in t-tests.
doi:10.1371/journal.pone.0008478.g004
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in AChR aggregation because the embryos injected with mutant
cortactin mRNA died before reaching a stage (,40 or later) when
NMJs can be reliably identified by BTX-labeling. We therefore
adopted an alternative approach for testing cortactin’s function, an
approach that has been successfully used by us [34] and by others
[23] in which myotomal muscle cells and spinal neurons are
isolated from early embryos (,stage 20–22) and plated together.
In these nerve-muscle co-cultures AChR clustering is triggered in
response to innervation, and when nerve and muscle cells isolated
from normal and mRNA-injected embryos are mixed together,
nerve or muscle can be manipulated selectively with exogenous
molecules (Methods). In this experimental system NMJ formation
can be observed and quantified by R-BTX-labeling, which is used
to monitor the focal aggregation of AChRs at nerve-muscle
contacts [34]. When we examined contacts between normal spinal
neurons and muscle cells expressing GFP or the GFP-tagged
cortactin proteins (Fig. 7), robust AChR clustering was detected at
innervation sites in muscle cells expressing GFP (panels A–D) or
GFP-tagged wild-type cortactin (E–H); in contrast, in cells
expressing GFP-tagged phospho-mutant cortactin, often no
synaptic AChR clustering was detected (I–J) or only weak and
loosely organized AChR clusters were found (K–L). We also
observed cases in which the same neurites contacted both mutant
cortactin-expressing cells and normal cells present side-by-side,
and here we found that AChR clustering was strongly induced in
the normal cells but not mutant cells (M–N). In cells expressing
GFP, wild-type and mutant cortactin we identified 168–225 nerve-
Figure 5. Inhibition of agrin-induced AChR clustering by forced expression of phospho-mutant cortactin in myotubes. To examine
the effect of exogenous cortactin proteins on AChR clustering, C2 myotubes were transfected with mRNAs encoding GFP (Ctl) or GFP-tagged
phospho-mutant (3YF) cortactin or wild-type (WT) cortactin. After treating myotubes with agrin overnight, cells expressing exogenous proteins (A,D ,
G; asterisks) were identified by green fluorescence (B, E, H) and the AChR clusters present on the surface of these cells were examined by R-BTX-
labeling (C, F, I; arrows). Forced expression of the phospho-mutant, but not wild-type, cortactin reduced the number and lengths of agrin-induced
AChR clusters in myotubes. J. To biochemically confirm the expression of exogenous cortactin proteins in myotubes, extracts prepared from
myotubes transfected with mRNAs encoding GFP, GFP-tagged WT and 3YF cortactin were immuno-blotted with anti-cortactin monoclonal antibody
mAb4F11. Myotubes transfected with GFP mRNA (G) contained full-length endogenous cortactin (arrow on left), but those transfected with WT- and
3YF-cortactin mRNAs contained endogenous cortactin plus a protein (,25 kD larger) corresponding to exogenous, GFP-tagged cortactin (asterisk).
MW marker positions are indicated on the right. K-L. Myotubes transfected with GFP or GFP-tagged cortactin proteins were selected randomly and
the numbers and lengths of the AChR clusters present on their surface were determined; data from five separate transfection experiments were
pooled and normalized relative to values obtained from GFP-tranfected cells. Fewer (K) and smaller (L) AChR clusters were present in myotubes
expressing phospho-mutant cortactin than in cells expressing GFP alone or WT-cortactin-GFP. Mean and SEM values are shown, *P,0.05.
doi:10.1371/journal.pone.0008478.g005
Cortactin and NMJ Formation
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innervation sites as those with or without AChR clusters; the
quantified results showed that in mutant cortactin cells, taking into
account even loosely organized AChR clusters (as in L), nerve-
induction of AChR aggregation was only half as effective as that in
GFP and wild-type cortactin cells (Fig. 7O).
Discussion
In this study examining the molecular regulation of AChR
aggregation at the NMJ we obtained these novel results: one,
proteins of the Arp2/3 complex and cortactin (which can together
promote actin polymerization) were co-distributed at AChR
clustering sites (where F-actin assembly occurs). Two, AChR
clusters were enriched in cortactin phosphorylated on its src-target
tyrosine residues, whose phosphorylation enhances Arp2/3-
mediated actin polymerization [33]. Three, treatment of myotubes
with agrin increased the phosphorylation of cortactin on tyrosine
residues, including those known to be targeted by src. Four, forced
expression in myotubes of a cortactin mutant lacking these (three
major) src-target sites inhibited agrin-induced AChR clustering, as
did the depletion of endogenous cortactin in myotubes using
RNAi. And five, disruption of normal cortactin signaling in muscle
cells by expression of the dominant-negative cortactin mutant
inhibited the aggregation of AChRs at innervation sites. We
propose that agrin/MuSK signaling acts on cortactin through src
(and possibly other) tyrosine kinases, and that cortactin, on its own
or with proteins such as Nck1, N-WASP and components of the
Arp2/3 complex, promotes actin polymerization and AChR
clustering at the NMJ (Fig. 8).
Diverse cellular mechanisms collaborate to generate and
maintain high-density AChR aggregates at the NMJ. Muscle-
surface AChRs are selectively clustered in the synaptic region of
muscle, the clustered AChRs are metabolically stabilized, and
AChRs and many proteins that promote their synaptic accumu-
lation are synthesized at high levels in the sub-synaptic domains of
myotubes [2,12,13,37]. The first of these mechanisms – synaptic
AChR clustering – has arguably been studied most extensively and
current evidence supports the following (simplified) view of the
molecular pathway involved: agrin secreted by nerve activates
MuSK through the protein Lrp4 [10,11], and MuSK, together
with binding partners dok-7 [6] and Tid1 [38], triggers
Figure 6. Inhibition of agrin-induced AChR clustering by down-regulation of cortactin expression in myotubes. C2 myotubes
generated from myoblasts transfected with control siRNAs (A-C) or a pool of siRNAs directed against mouse cortactin (D-F) (both mixed with a cDNA
encoding GFP) were incubated overnight in differentiation medium containing agrin before labeling with R-BTX. Transfected myotubes (A, D;
asterisks) were identified by green fluorescence (B, E), and the AChR clusters present on their surface (C, F; arrows) were counted and the lengths of
these clusters were measured. G. To demonstrate that siRNAs against cortactin knocked down cortactin expression, in each experiment extracts were
prepared from myotubes generated from myoblasts transfected in parallel and maintained under conditions identical to those used for examining
agrin-induced AChR clustering. Extracts of cells transfected with GFP cDNA plus control (p120ctn) siRNA (Ctl; left lane), cortactin siRNA (middle lane)
or GFP cDNA alone (right lane) were immuno-blotted with antibodies against cortactin (upper blot) or tubulin (lower blot). The cortactin siRNA
suppressed the expression of cortactin without affecting unrelated proteins (such as tubulin, which is also shown here to demonstrate equal protein
loading), and cortactin’s expression was not affected by control siRNAs or by transfection procedures (where only GFP cDNA was used). From four
transfection experiments AChR cluster data from control (Ctl) and mouse cortactin (msCort) siRNA-transfected myotubes were pooled and
normalized relative to those obtained from cells transfected with the control siRNA. These results showed that agrin-induced AChR cluster numbers
(H) and lengths (I) were significantly lower in myotubes expressing reduced levels of endogenous cortactin compared to those expressing normal
levels of cortactin. Mean and SEM values are shown, *P,0.05.
doi:10.1371/journal.pone.0008478.g006
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2+, various kinases
and phosphatases and Rho-family GTPases to direct AChR
aggregation in an actin polymerization-dependent manner
[12,39].
New F-actin synthesis occurs at AChR clustering sites in muscle
cells [19,20] and likely depends on the combined activity of Rho
GTPases and their regulators and effectors that function in agrin/
MuSK signaling [21,23,24,25]. Rho GTPases are potent stimu-
lators of the Arp2/3 complex, which enhances actin polymeriza-
tion in many types of cells [31]. Arp2/3 complex-dependent actin
polymerization is activated by proteins such as WASP/N-WASP
and Scar/WAVE, and the binding of Rac and Cdc42 GTPases
enables WASP/N-WASP and Scar/WAVE to stimulate the
Arp2/3 complex [30,31]. Thus, our detection of Arp2/3 complex
proteins at AChR clusters suggests that GTPase signaling
accelerates Arp2/3-dependent F-actin assembly at synapses
(Fig. 8).
In this study expression of either mutant cortactin or cortactin
siRNAs in muscle cells inhibited agrin/nerve-dependent AChR
aggregation partially rather than fully. Although this could have
been due to incomplete disruption of normal cortactin function in
the muscle cells, it could also be because of cortactin being one of
many Arp2/3 complex/actin-regulators (such as the GTPases) at
the synapse. Our observation that over-expression of wild-type
cortactin in myotubes did not enhance AChR clustering is
consistent with the latter view. It should be of interest to
investigate in future studies the extent to which the inhibition of
both cortactin and Rho-family GTPases blocks agrin-induced
AChR clustering.
We have shown here that cortactin was colocalized with the
Arp2/3 complex at AChR clustering sites. Notably, tyrosine
phosphorylated-cortactin was enriched at AChR clusters and the
phosphorylation of cortactin’s src-target sites was enhanced by
agrin treatment of muscle cells. Although cortactin was originally
identified as a major src kinase-substrate in cells, the influence
of phosphorylation on cortactin-dependent regulation of actin
polymerization long remained unclear [29,40]. An elegant
biochemical study carried out recently, however, has indicated a
Figure 7. Suppression of synaptic AChR aggregation by phospho-mutant cortactin expressed selectively in muscle cells. Xenopus
embryonic muscle cells expressing GFP (A-D) and GFP-tagged wild-type cortactin (WT-cort; E-H) and phospho-mutant cortactin (3YF-cort; I-N) were
co-cultured with spinals neurons for 1 d and then labeled with R-BTX to visualize AChR clusters. Cells expressing the exogenous proteins fluoresced
green and AChR clusters appeared red, as shown in this figure with 2-3 representative examples of nerves contacting muscle cells with GFP or GFP-
tagged cortactin proteins. In the GFP and WT-cort muscle cells (A-H), AChRs were tightly clustered (arrows) along nerve-contacts identified (tracedi n
white in colored panels) but this was not the case in 3YF-cort cells where nerves often induced no AChR clustering (J) or induced few clusters that
were loosely organized (L; arrowheads). We found cases where the same neurites moved across normal muscle cells and 3YF-cells (M-N) and in such
cases synaptic AChR clustering was robust in the normal cells (arrows) but not mutant cells (arrowheads). O. The percentages of nerve-contacts with
AChR clusters were determined by examining several co-cultures with muscle cells expressing GFP or the GFP-tagged cortactin proteins (see
Methods) and these values were normalized relative to numbers obtained from examining nerve-contacts on GFP-cells. In muscle cells expressing
phospho-mutant cortactin, synaptic AChR clustering was almost halved. Nerve-muscle contacts examined: GFP cells, 168; WT-cort cells, 214; 3YF-cort
cells, 225; mean and SEM shown, *P,0.0001.
doi:10.1371/journal.pone.0008478.g007
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target sites can stimulate F-actin assembly [33]. Using purified
proteins this study showed that phosphorylation of cortactin by src
enables the formation of a complex made up of cortactin and the
SH2 domain-containing adapter Nck1, plus N-WASP or the
WASP-interacting protein, WIP. Consistent with earlier work [41]
cortactin stimulated Arp2/3-dependent polymerization of actin
by its N-terminal acidic region; this activity was enhanced
following src-phosphorylation of cortactin, which promoted
Nck1-binding and through Nck1 the recruitment of WIP [33].
After src-phosphorylation cortactin could also be linked by Nck1
to N-WASP, and this complex (through the ‘‘VCA’’ domain of
N-WASP) more robustly stimulated F-actin assembly by Arp2/3
than cortactin or N-WASP alone. Importantly, a phospho-mutant
(3YF) cortactin was used to demonstrate that src-dependent
enhancement of cortactin’s ability to stimulate Arp2/3 (through
Nck1 and N-WASP or WIP) requires the Y421, Y466 and Y482
sites of cortactin [33]. Forced expression of the same 3YF-mutant
cortactin in myotubes, or the suppression of cortactin expression
using RNAi, inhibited agrin-induced AChR clustering in this
study. It is known that src kinases are rapidly activated by agrin-
stimulation of MuSK and that they phosphorylate MuSK, AChRs
and associated proteins [35]. Moreover, like phospho-cortactin
(this study), activated-src kinases are enriched at AChR clustering
sites in situ [12]. Thus src-cortactin signaling may be spatially
restricted to the synaptic regions of muscle where intimate
coupling of MuSK and src activation could lead to rapid tyrosine
phosphorylation of cortactin; this, in turn, could locally enhance
Arp2/3-dependent actin polymerization to generate ‘‘traps’’ that
capture mobile AChRs.
Currently a role of cortactin at the NMJ in vivo cannot be
directly tested because suitable models – viable animals with global
or muscle-specific cortactin gene deletion – are unavailable.
Moreover, through our own work we noted that Xenopus embryos
which had been injected with the phospho-mutant cortactin
mRNA failed to grow to a stage at which NMJs in the developing
tail could be studied. We were, however, successful in using this
dominant-negative approach to show that interference with
phosphorylation-dependent cortactin signaling in muscle is
sufficient for inhibiting nerve-induced AChR clustering, and by
extension NMJ formation, in culture. Interestingly, others have
studied mice lacking src kinase activity in muscle and have shown
that while NMJs can develop in the muscles of these mice, the
synaptic AChR aggregates found are less stable than their
counterparts in the muscles of normal mice [42]. One explanation
for this observation is that src binds to AChRs and phosphorylates
them, which enhances the cytoskeletal linkage of AChRs through
rapsyn [43,44,45,46]. The results of this study raise the additional
possibility that in the absence of normal src activity, sub-optimal
signaling by cortactin leads to the assembly of synaptic scaffolds
which hold AChRs poorly at NMJs.
Properly balanced src signaling is important for normal AChR
clustering at the NMJ [47], but what all targets of src influence
AChR clustering at the NMJ is incompletely understood. By
uncovering a role of the src-substrate cortactin in AChR clustering
this study suggests a previously unappreciated way by which src
could regulate AChR aggregation at the NMJ. Interestingly, two
other src-substrates we previously identified as targets in agrin/
MuSK signaling produced effects distinct from those described
here for cortactin: p120ctn promoted myopodial induction in
response to agrin [34], whereas signal-regulatory protein a1
(SIRPa1) stimulated the tyrosine phosphatase Shp2 to limit
MuSK-dependent AChR clustering [48] and to also facilitate
the dispersal of pre-patterned AChR clusters by synaptogenic
stimuli [14]. Intriguingly, cortactin can participate in p120ctn
signaling in epithelial cells [49] and can act together with the
p120ctn-relative d-catenin in generating filopodia-like dendritic
protrusions in neurons [50]. Moreover, cortactin itself also affects
dendritic spine morphogenesis and remodeling, with the depletion
of cortactin in neurons causing a reduction in spines [51,52].
Thus, cortactin-dependent actin polymerization triggered by src
could potentially facilitate p120ctn-mediated myopodial assembly
at the NMJ as well as synapse formation in central neurons. And,
although it is not known which phosphatases dephosphorylate
cortactin in muscle cells, the spread of phosphatase activity
initiated by agrin/MuSK [12,14,53] may bring about the
dephosphorylation of extrasynaptic cortactin to maintain efficient
actin polymerization by src-cortactin signaling selectively at
developing NMJs where agrin stimulates MuSK. Future studies
investigating the spatiotemporal control of cortactin’s phosphor-
ylation levels during neuronal synapse development and testing
whether that phosphorylation affects cortactin’s ability to influence
Figure 8. Cortactin signaling in agrin-dependent AChR clus-
tering: a model. Activation of MuSK by agrin induces AChR clustering
in an actin polymerization-dependent manner. This model depicts a
possible way in which cortactin signaling might promote the AChR
clustering process. Initiation of intracellular signaling by the activated
MuSK complex could enhance cortactin’s tyrosine phosphorylation
through src family tyrosine kinases (SFKs) (and possibly other kinases
such as abl), and cortactin, in turn, could increase actin polymerization.
Alternatively, cortactin might trigger actin polymerization by activating
the Arp2/3 complex, either on its own or in concert with WASP-related
proteins (N-WASP, WIP, etc.) to which it could be linked by the adapter
Nck. In parallel, via other signaling intermediates, MuSK could stimulate
Rho-family GTPases and, through them, F-actin assembly. Such
enhanced and dynamic actin polymerization at synaptic sites could
generate a scaffold which ‘‘traps’’ AChRs through rapsyn.
doi:10.1371/journal.pone.0008478.g008
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Agrin was obtained from the conditioned medium of HEK293
cells transfected with a plasmid encoding neural agrin [54].
Recombinant heparin-binding growth-associated molecule (HB-
GAM) was generously provided by Dr. Heikki Rauvala (University
of Helsinki). Na-pervanadate, a potent tyrosine phosphatase
inhibitor, was prepared by mixing 10 mM Na-orthovanadate
with 1.7% hydrogen peroxide in a 50:1 ratio just before use and
diluting this solution as needed [53]. These reagents were
purchased: rhodamine-conjugated a-bungarotoxin (R-BTX) (Mo-
lecular Probes; Eugene, OR, USA); monoclonal antibodies against
cortactin (4F11) and phosphotyrosine (4G10) and a rabbit
polyclonal antibody against p34arc (Upstate Biotechnology; Lake
Placid, NY, USA); rabbit polyclonal antibodies against cortactin
phosphorylated on Y421, Y466 or Y482 (Cell Signaling
Technology; Danvers, MA, USA); rabbit polyclonal antibodies
against Arp2 and Y390-phosphorylated AChR b-subunit (Santa
Cruz Biotechnology; Santa Cruz, CA, USA); monoclonal anti-
Shp2 and anti-neurexin-1 antibodies (BD Biosciences; San Jose,
CA, USA); monoclonal anti-a-tubulin antibody DM1A (Sigma; St
Louis, MO, USA); rhodamine- and FITC-conjugated secondary
antibodies (Zymed; South San Francisco, CA, USA); horseradish-
peroxidase (HRP)-conjugated secondary antibodies (Jackson Im-
muno Research Laboratories; West Grove, PA, USA); and Triton
X-100 (TX-100) and West Pico enhanced chemiluminescence
(ECL) reagent (Pierce; Rockford, IL, USA).
Cell Cultures
Primary cultures of Xenopus myotomal muscle cells were
prepared from stage 20–22 embryos as described previously [55]
in accordance with HKUST’s established animal handling and
care procedures. Muscle cells were plated on glass coverslips
coated with entactin-collagen-laminin substrate (Upstate Biotech-
nology) and used within one week. For some experiments neural
tubes of stage 20–22 embryos were dissociated and spinal neurons
were seeded on muscle cells plated 3–5 d earlier; these nerve-
muscle co-cultures were examined 1 d later [34]. C2 mouse
myotube cultures were prepared by growing myoblasts (purchased
from ATCC, Manassas, VA, USA) on glass coverslips or in culture
dishes in DMEM containing 20% fetal bovine serum (growth
medium) until confluence and then inducing differentiation by
changing the medium to DMEM containing 2% horse serum
(differentiation medium); fresh differentiation medium was added
each day for 4–5 d [53].
Agrin-Treatment, Cell Extract Preparation,
Immuno-Precipitation/Blotting
Differentiated C2 myotubes in culture dishes were incubated for
1 h in fresh differentiation medium without or with added agrin
(plus 10 mM Na-pervanadate). After rinsing with cold phosphate
buffered saline (PBS), extracts were prepared using a TX-100
buffer (100 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1%
TX-100, 1 mM Na-pervanadate) [53], with 1 ml buffer being
added to a 10 cm culture dish of cells. To clarified extracts anti-
cortactin or control antibodies and Protein A/G agarose beads
(Santa Cruz Biotechnology) were added, and after mixing for 2 h
at room temp the beads were spun down, washed extensively with
Tris-buffered saline containing 0.1% TX-100 and then mixed with
SDS-electrophoresis sample buffer to elute immuno-precipitated
proteins. Samples were electrophoresed, transferred to PVDF
membranes and probed with primary antibodies and HRP-linked
secondary antibodies for ECL-based detection.
Synthesis of mRNAs, Myotube Transfection
Wild-type and phospho-mutant mouse cortactin cDNAs were
gifts from Drs. Tom Parsons (University of Virginia) and Xi Zhan
(University of Maryland), respectively. In the phospho-mutant
cortactin (3YF) construct, three src target sites – Y421, Y466 and
Y482 – were changed to non-phosphorylatable Fs [36]. Both wild-
type and mutant cortactin proteins were tagged with green
fluorescent protein (GFP) by inserting the cortactin cDNAs into
pEGFP-N1 plasmid (Clonetech); the cortactin-GFP sequences
were subcloned into pCS2+ vector [19] and then into pcDNA3.1.
The cortactin-GFP encoding plasmids and pCS2+ vector with an
insert encoding only GFP were linearized and used for mRNA
preparation with the mMessage mMachine mRNA synthesis kit
from Ambion, Inc. (Austin, TX, USA). The mRNAs were diluted
with Opti-MEM I medium (GIBCO) before using Lipofectamine
2000 (Invitrogen) to transfect them into myotubes that had been
maintained in differentiation medium for 4 d; 1 mg mRNA was
used per 3.5 cm dish of cells [48]. Myotubes were incubated in
transfection solutions for 6 h and then transferred back to
differentiation medium before use in experiments.
Cortactin Knockdown by RNA Interference
A pool of four small interfering RNAs (siRNAs) targeting mouse
cortactin and several other siRNAs against unrelated proteins were
purchased from Dharmacon RNA Technologies (Lafayette, CO,
USA); the siRNAs (100 pmol) were mixed with GFP cDNA (1 mg)
and used for transfecting C2 myoblasts (with Lipofectamine 2000)
grown in 3.5 cm culture dishes or on glass coverslips placed within
the dishes. Transfection was carried out (for 6 h) when cells were
,60% confluent, and the cells were then put back in growth
medium to allow them to reach confluence before transferring
them to differentiation medium [53]. After 4 d myotubes were
treated overnight with agrin and used for examining total cortactin
expression (by immuno-blotting extracts prepared from myotubes
growing in dishes) as well as GFP fluorescence and AChR
clustering (after R-BTX labeling of cells growing on coverslips
placed in the same dishes).
Co-Culturing of Xenopus Neurons with Muscle Cells
Expressing Exogenous Proteins
To express GFP-tagged wild-type and mutant cortactin (or
GFP) selectively in muscle cells, mRNAs encoding these proteins
were injected into one cell of 2-4-cell stage Xenopus embryos;
myotomal muscle cells were cultured from the embryos after they
had developed to stage 20–22 [34]. Muscle cells were maintained
for 3–5 d and then spinal neurons from normal (uninjected)
embryos were seeded on them and allowed to spread for 1 d.
Labeling, Microscopy and Quantification of AChR
Clustering
AChRs on Xenopus muscle cells were labeled with R-BTX
either before exposing cells to control medium or medium
containing agrin or HB-GAM beads, or after innervation in co-
culture experiments. To localize Arp2/3 complex proteins,
phospho-cortactin, etc., cells were fixed with cold ethanol, blocked
with PBS containing bovine serum albumin, and labeled with
primary and fluorescent-secondary antibodies. Cells were exam-
ined with a 63X, 1.4 n.a. lens using an Olympus IX70 inverted
Cortactin and NMJ Formation
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camera controlled by MetaMorph software (Universal Imaging,
West Chester, PA, USA).
To analyze AChR clustering in C2 myotubes, cells were treated
with agrin overnight, labeled with R-BTX, fixed with 4%
paraformaldehyde and then mounted on slides. All transfection
assays were carried out multiple times with duplicate or triplicate
samples and AChR clusters were examined in (only) transfected
(green fluorescent) myotubes. After selecting transfected myotubes
randomly, all AChR clusters on those myotubes were counted and
their lengths were measured. Average numbers of AChR clusters
per myotube and the average lengths of clusters were calculated
and normalized relative to values obtained for clusters from cells
expressing GFP only.
In Xenopus nerve-muscle co-cultures, effects of exogenous
proteins on synaptic AChR clustering was quantified as follows: in
R-BTX-labeled live cultures, nerve-muscle pairs were randomly
identified (in phase-contrast) in which nerves directly contacted
muscle cells; then, if the muscle cell was found to be green
fluorescent (indicating the expression of GFP- or GFP-tagged
cortactin proteins), we determined (using the rhodamine filter)
whether or not AChRs were concentrated focally at nerve-muscle
contacts. Co-cultures were prepared using muscle cells from
several separate batches of mRNA-injected embryos and neurons
from normal embryos and in each preparation 3–6 coverslips were
examined. The number of nerve-muscle contacts and the number
of contacts with AChR clusters were determined and the latter
values were divided by the former; pooled data were normalized
using numbers obtained from co-cultures in which muscle cells
only expressed GFP.
Supporting Information
Table S1 Association of phospho-cortactin with AChR clusters.
Found at: doi:10.1371/journal.pone.0008478.s001 (0.03 MB
DOC)
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